New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
09:25 EDTMYL, MYL, ATI, ATI, IIVI, IIVI, KOP, KOP, ANSS, ANSS, FSTR, FSTR, BBOX, BBOX, KMT, KMT, STBA, STBA, CCC, CCC, EQT, EQT, WCC, WCCCFA Society of Pittsburgh to hold a conference
2014 INVESTPennsylvania Equity Conference to be held in Pittsburgh on May 29 with webcasted company presentations to begin at 9:25 am; not all company presentations may be webcasted. Webcast Link
News For MYL;EQT;CCC;STBA;KMT;BBOX;FSTR;ANSS;KOP;IIVI;ATI;WCC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
11:00 EDTMYLMylan expands Hepatitis C licensing agreement with Gilead
Mylan (MYL) announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences (GILD) to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816, once approved, in 91 developing countries. The single tablet regimen is being evaluated in Phase 3 clinical studies for the treatment of all six genotypes of hepatitis C. If approved by regulatory authorities, the sofosbuvir/GS-5816 regimen would become the first all-oral single tablet regimen for all hepatitis C genotypes. A pan-genotypic therapeutic option is particularly important for developing countries, where genotype testing is often unreliable or not readily available. This agreement is in addition to the licensing and technology transfer agreement that Mylan entered into with Gilead in September 2014, which grants Mylan the non-exclusive rights to manufacture and distribute sofosbuvir and ledipasvir/sofosbuvir in 91 developing countries. Mylan also partners with Gilead on expanding access to high quality, affordable antiretrovirals for the treatment of HIV/AIDS in India and other developing countries.
January 21, 2015
07:16 EDTKOPKoppers Holdings sells utility pole business to Cox Industries
Cox Industries has completed the acquisition of the U.S. utility pole business from Koppers Inc., a wholly owned subsidiary of Koppers Holdings. The transaction includes the sale of Koppers existing pole inventory, lease agreements related to multiple pole distribution yards Koppers maintains throughout the country, and the purchase of related manufacturing assets. The transaction does not include the sale of Koppers wood treating facility located in Florence, South Carolina.
January 20, 2015
14:37 EDTMYLTeva generic competition to Copaxone pushed out by ruling, says BMO Capital
Subscribe for More Information
12:56 EDTMYLMylan says continues to believe '808 patent is 'invalid'
Subscribe for More Information
10:40 EDTMYLMomenta Pharma sinks after Supreme Court rules on Copaxone
Subscribe for More Information
08:34 EDTKOPKoppers Inc. acquires creosote distribution business of KMG Chemicals for $12.5M
Subscribe for More Information
08:33 EDTKOPKMG Chemicals announces sale of creosote distribution assets to Koppers
KMG Chemicals (KMG) announced that it has sold its creosote distribution business to Koppers Inc., a wholly-owned subsidiary of Koppers Holdings Inc. (KOP). Assets included in the transaction are KMG’s rail car and tank terminal leases, and creosote inventory. KMG estimates that cash proceeds from the sale will be approximately $15.5M, which includes approximately $3M worth of inventory. The asset sale closed concurrently with the signing of the asset purchase agreement. KMG fully retains its North American pentachlorophenol manufacturing operations, and the company will continue to produce and supply this important wood preservative used for the treatment of wooden utility poles and cross-arms.
08:31 EDTKOPKoppers Inc. sells U.S. utility pole business to Cox Industries
Subscribe for More Information
07:08 EDTATIAllegheny Technologies sees FY15 CapEx approx. $290M
Sees FY15 pre-tax retirement benefit expense about $78M. Expects PQ titanium sponge qualification costs to impact first half 2015 operating profit and costs attributable to production inefficiencies to impact the second half 2015 until optimum utilization levels are achieved.
07:07 EDTATIAllegheny Technologies reports Q4 continuing ops EPS 18c, consensus 0c
Subscribe for More Information
January 15, 2015
14:31 EDTMYLMylan launches generic Epivir-HBV tablets
Mylan (MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's (GSK) Epivir-HBV. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. Lamivudine Tablets, 100 mg, had U.S. sales of approximately $18.1M for the 12 months ending September 30, 2014, according to IMS Health. Currently, Mylan has 284 ANDAs pending FDA approval representing $109.1B in annual brand sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $29.3B in annual brand sales, for the 12 months ending June 30, 2014, according to IMS Health.
09:34 EDTKOPKoppers Holdings downgraded to Neutral from Buy at Monness Crespi
Subscribe for More Information
09:33 EDTIIVIII-VI initiated with a Buy at Sidoti
January 14, 2015
09:03 EDTSTBAS&T Bancorp expands into western New York
S&T Bank announced its expansion into western New York with the opening of a new loan production office located on 242 West Main Street.
08:43 EDTKOPKoppers Holdings announces delay of North American CMC restructuring project
Subscribe for More Information
08:42 EDTKOPKoppers Holdings sees legal entity reorganization raising EPS by 30c
Subscribe for More Information
January 13, 2015
11:31 EDTATIBofA/Merrill metals & steel analysts hold analyst/industry conference call
Subscribe for More Information
January 12, 2015
07:32 EDTBBOXSidodi to hold a forum
Emerging Growth Institutional Investor Forum is being held in New York on January 12.
07:17 EDTMYLJPMorgan to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use